ETPB in the News
White House Mental Health Virtual Event: How Science Offers Hope for Treatment-Resistant Depression
Dr. Zarate speaks to Dr. Carrie D. Wolinetz, Deputy Director for Health & Life Sciences at the White House Office of Science and Technology Policy about work to develop new medications for treatment-resistant depression and describes arc from fundamental research to now approved treatment.
Dr. Carlos Zarate – Ketamine to Combat Depression
January 13, 2021 • Science Update
NIMH Director to Discuss Advances in Treating Major Depression
February 14, 2020 • Press Release
NIMH’s Carlos Zarate Jr., M.D., Elected to National Academy of Medicine
October, 22, 2020 • Institute Update
Side effects mild, brief with single antidepressant dose of intravenous ketamine
November 15, 2019 • News Release
Shake it off – Boosting your Mood
January 2019 • Press Release
NIMH: Ketamine-Like Hallucinogens May Offer New Hope for Treatment-Resistant Depression
November 16, 2017 • Press Release
Ketamine Lifts Depression Via a Byproduct of its Metabolism
May 4, 2016 • Press Release
NIH Nearly Doubles Investment in BRAIN Initiative Research
October 13, 2016 • Press Release
Rapid Agent Restores Pleasure-seeking Ahead of Other Antidepressant Action
October 17, 2014 • Press Release
Imaging Biomarker Predicts Response to Rapid Antidepressant: Signals Dysfunction in Brain System Targeted by Scopolamine: Maura Furey on Scopolamine Research
February 4, 2013 • Press Release
Webinar on Ketamine and Next Generation Therapies Featuring NIMH’s Carlos A. Zarate, M.D.
August 6, 2013• Science Update
Brain Signal ID's Responders to Fast-Acting Antidepressant: Biomarkers Help Pinpoint Mechanisms, Predict Outcomes
August 3, 2012 • News Release
Experimental Agent Briefly Eases Depression Rapidly in Test
December 11, 2012 • Press Release
Rapid Antidepressant Action of Common Medication Confirmed by Repeat Trial: Maura Furey on Scopolamine Research
May 4, 2010• Science Update
Study Shows Possibilities for Predicting How Patients Will Respond to Antidepressants
July 22, 2010 • Science Update
Experimental Medication Lifts Depression Symptoms in Bipolar Disorder Within an Hour
August 6, 2010• Science Update
Millisecond Brain Signals Predict Response to Fast-Acting Antidepressant: Electromagnetic Biomarker Could Minimize Trial-and-Error Prescribing
October 2, 2008 • Press Release
Depression
The need for speed: A new approach to treating depressive disorders
NIH Intramural Research Program Research
From Despair to Hope in Hours
NIH Intramural Research Program Research in Action
Ketamine: A New (and Faster) Path to Treating Depression
NIMH Strategic Plan Highlight
Depression Research: Relief in Hours?
Summer 2007 Issue • MedlinePlus
Brain Scans Give Clues to Antidepressant's Effects
NIH News in Health
Bipolar Disorder
Major Ups and Downs: Bipolar Disorder Brings Extreme Mood Swings
NIH News in Health
White House Mental Health Virtual Event: How Science Offers Hope for Treatment-Resistant Depression Carlos Zarate [July 22, 2022]
Astute Clinician Lecture: “Relief from severe depression and suicidal ideation within hours: from synapses to symptoms ” [Nov 24, 2015]
Ketamine and Depression: From Despair to Hope in Hours : Carlos Zarate, NIH Clinician Scientist [Apr 4, 2013]
Webinars
NIMH
Treatment-Resistant Depression & the Neurobiology of Suicide
Experts from the ETPB team hosted a workshop titled “ Treatment-Resistant Depression & the Neurobiology of Suicide ” [December 6, 2018]
Is Shock Therapy Making a Comeback?
CBS News: 60 Minutes, May 13, 2018
Depression Treatments Inspired By Club Drug Move Ahead In Tests
NPR, May 28, 2015
The Search for a 'Safer' Ketamine -- Can glutamate drugs treat the worst cases of depression -- and keep pharma in psychiatry?
MEDPAGE Today, Nov 2, 2015
Brain Study Seeks Roots of Suicide
Scientific American, Nature: Mind, November 25, 2015
Ketamine and Next Generation Therapies - Carlos Zarate, M.D.
Brain & Behavior Research Foundation , August 14, 2013
Could A Club Drug Offer 'Almost Immediate' Relief From Depression? [Part 1]
NPR Morning Edition, January 30, 2012
'I Wanted To Live': New Depression Drugs Offer Hope For Toughest Cases ;[Part 2]
NPR Morning Edition, January 31, 2012
Ketamine Relieves Bipolar Depression, Suicidal Thoughts in Less Than an Hour
PsychCentral, May 31, 2012
Carlos Zarate MD, 2011 Bipolar Mood Disorders Prize
Brain & Behavior Research Foundation , November 15, 2011
Breast Cancer Med Reduces Mania
PsychCentral, September 12, 2007
NIMH Twitter Chat: Depression
In recognition of National Depression Screening Day, NIMH hosted a Twitter chat on depression, a common but serious mood disorder. This chat covered the signs and symptoms, risk factors, and treatments for depression. Two experts, Dr. Lawrence Park and Dr. Bashkim Kadriu, were available to answer questions.[Oct 11, 2018]
NIH Intramural Reddit: “Ask Me Anything” with Dr. Carlos Zarate Jr. - Developing Novel Therapeutics for Depression
The National Institute of Mental Health (NIMH) and the National Institutes of Health (NIH)’s Intramural Research Program (IRP) teamed up for a Reddit “Ask Me Anything” (AMA) discussion with Dr. Carlos Zarate Jr, chief of NIMH’s Experimental Therapeutics & Pathophysiology Branch. [Nov 13, 2018]
During the Reddit AMA, Dr. Zarate answered questions from the public about current treatments for depression and the latest research efforts to develop cutting-edge therapies for the condition.
View the full AMA on Reddit , or for a summary, visit the NIH’s Intramural Blog: Shedding Light on the Deep Darkness of Depression [Nov 15, 2018]